Potent antagonism by BIM-23056 at the human recombinant somatostatin sst5 receptor-Reference-Cited by-同舟云学术

Potent antagonism by BIM-23056 at the human recombinant somatostatin sst5 receptor

Published:1996-06 Issue:3 Volume:118 Page:445-447
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Wilkinson Graeme F.,Thurlow Richard J.,Sellers Lynda A.,Coote Jim E.,Feniuk Wasyl,Humphrey Patrick P.A.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1476-5381.1996.tb15423.x/fullpdf

Reference6 articles.

1. Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1-5, in transfected COS-7 cells;AKBAR;FEBS Lett.,1994

2. Classification and nomenclature of somatostatin receptors;HOYER;Trends Pharmacol. Sci.,1995

3. International union of pharmacology committee on receptor nomenclature and drug classification. IX. Recommendations on terms and symbols in quantitative pharmacology;JENKINSON;Pharmacol. Rev.,1995

4. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5);PATEL;Endocrinology,1994

5. Bicistronic vector for the creation of stable mammalian cell lines that predispose all antibiotic resistant cells to express recombinant protein;REES;Biotechniques,1996

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signalling mechanism for somatostatin receptor 5-mediated suppression of AMPA responses in rat retinal ganglion cells;Neuropharmacology;2016-08

2. Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure;Cell Death & Disease;2016-03

3. Somatostatin receptor-mediated suppression of gabaergic synaptic transmission in cultured rat retinal amacrine cells;Neuroscience;2014-07

4. Somatostatin, Alzheimer's disease and cognition: An old story coming of age?;Progress in Neurobiology;2009-10

5. Somatostatin inhibits colon cancer cell growth through cyclooxygenase-2 downregulation;British Journal of Pharmacology;2008-09